References and Notes
<A NAME="RD30106ST-1A">1a</A>
Brown DJ. In Comprehensive Heterocyclic Chemistry
Vol. 3:
Katritzky AR.
Rees CW.
Scrieven EFV.
Pergamon;
Oxford:
1984.
Chap 2.13.
p.142-155
<A NAME="RD30106ST-1B">1b</A>
Callery P.
Gannett P. In Foye’s Principles of Medicinal Chemistry
Williams DA.
Lemke TL.
Lippincott Williams and Wilkins;
Philadelphia:
2002.
p.934-935
<A NAME="RD30106ST-1C">1c</A>
Jain KS.
Chitre TS.
Miniyar PB.
Kathiravan MK.
Bendre VS.
Veer VS.
Shahane SR.
Shishoo CJ.
Curr. Sci.
2006,
90:
793
<A NAME="RD30106ST-2">2</A>
Botta M.
Corelli F.
Maga G.
Manetti F.
Renzulli M.
Spadari S.
Tetrahedron
2001,
57:
8357
<A NAME="RD30106ST-3">3</A>
Garg R.
Gupta SP.
Gao H.
Babu MS.
Debnath AK.
Hansch C.
Chem. Rev.
1999,
99:
3525
<A NAME="RD30106ST-4">4</A>
Botta M.
Occhionero F.
Nicoletti R.
Mastromarino P.
Conti C.
Magrini M.
Saladino R.
Bioorg. Med. Chem.
1999,
7:
1925
<A NAME="RD30106ST-5A">5a</A>
Hurst D. In An Introduction to Chemistry & Biochemistry of Pyrimidines, Purines & Pteridines
Wiley;
Chichester:
1988.
<A NAME="RD30106ST-5B">5b</A>
Brown DJ. In The Pyrimidines
Interscience Publishers;
New York:
1994.
<A NAME="RD30106ST-6A">6a</A>
Zanatta N.
Flores DC.
Madruga CC.
Flores AFC.
Bonacorso HG.
Martins MAP.
Tetrahedron Lett.
2006,
47:
573
<A NAME="RD30106ST-6B">6b</A>
Jeong JU.
Chen X.
Rahman A.
Yamashita DS.
Luengo JI.
Org. Lett.
2004,
6:
1013
<A NAME="RD30106ST-6C">6c</A>
Mabry J.
Ganem B.
Tetrahedron Lett.
2006,
47:
55
<A NAME="RD30106ST-6D">6d</A>
Peng Z.
Journet M.
Humphrey G.
Org. Lett.
2006,
8:
395
<A NAME="RD30106ST-6E">6e</A>
Cernuchova P.
Vo-Thanh G.
Milata V.
Loupy A.
Jantova S.
Theiszova M.
Tetrahedron
2005,
61:
5379
<A NAME="RD30106ST-7A">7a</A>
Lin S.
Danishefsky SJ.
Angew. Chem. Int. Ed.
2002,
41:
512
<A NAME="RD30106ST-7B">7b</A>
Musso DL.
Cochran FR.
Kelley JL.
McLean EW.
Selph JL.
Rigdon GC.
Orr GF.
Davis RG.
Cooper BR.
Styles VL.
Thompson JB.
Hall WR.
J. Med. Chem.
2003,
46:
399
<A NAME="RD30106ST-7C">7c</A>
Petersen AB.
Petersen MA.
Henriksen U.
Hammerum S.
Dahl O.
Org. Biomol. Chem.
2003,
1:
3293
<A NAME="RD30106ST-8A">8a</A>
You J.
Drexler HJ.
Zhang S.
Fischer C.
Heller D.
Angew. Chem. Int. Ed.
2003,
42:
913
<A NAME="RD30106ST-8B">8b</A>
Yan Y.
Zhang X.
Tetrahedron Lett.
2006,
47:
1567
<A NAME="RD30106ST-8C">8c</A>
Zhang YJ.
Park JH.
Lee S.
Tetrahedron: Asymmetry
2004,
15:
2209
<A NAME="RD30106ST-9A">9a</A>
Ahmed S.
Boruah RC.
Tetrahedron Lett.
1996,
37:
8231
<A NAME="RD30106ST-9B">9b</A>
Boruah RC.
Ahmed S.
Sharma U.
Sandhu JS.
Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.
1999,
38:
274
<A NAME="RD30106ST-10A">10a</A>
Sharma U.
Ahmed S.
Boruah RC.
Tetrahedron Lett.
2000,
41:
3493
<A NAME="RD30106ST-10B">10b</A>
Boruah RC.
Ahmed S.
Sharma U.
Sandhu JS.
J. Org. Chem.
2000,
65:
922
<A NAME="RD30106ST-10C">10c</A>
Ahmed S.
Boruah RC.
Tetrahedron Lett.
1997,
38:
1845
<A NAME="RD30106ST-10D">10d</A>
Longchar M.
Chetia A.
Ahmed S.
Boruah RC.
Sandhu JS.
Synth. Commun.
2001,
31:
3281
<A NAME="RD30106ST-11A">11a</A>
Varma RS. In Microwaves: Theory and Application in Material Processing IV
Clark DE.
Sutton WH.
Lewis DA.
American Ceramic Society;
Westerville / OH:
1997.
p.357-365
<A NAME="RD30106ST-11B">11b</A>
Varma RS.
Dahiya R.
Tetrahedron
1998,
54:
6293
<A NAME="RD30106ST-11C">11c</A>
Bora U.
Saikia A.
Boruah RC.
Org. Lett.
2003,
5:
435
<A NAME="RD30106ST-12">12</A>
Chetia A.
Longchar M.
Lekhok KC.
Boruah RC.
Synlett
2004,
1309
<A NAME="RD30106ST-13A">13a</A>
Saikia A.
Barthakur MG.
Borthakur M.
Saikia CJ.
Bora U.
Boruah RC.
Tetrahedron Lett.
2006,
47:
43
<A NAME="RD30106ST-13B">13b</A>
Barhtakur MG.
Chetia A.
Boruah RC.
Tetrahedron Lett.
2006,
47:
4925
<A NAME="RD30106ST-14">14</A>
Simon C.
Constantieux T.
Rodriguez J.
Eur. J. Org. Chem.
2004,
4957
<A NAME="RD30106ST-15">15</A>
Representative Procedure for the Synthesis of 2′-Methyl-5α-cholest[2,3-
e
]pyrimidine (
4a):
3-Acetamido-2-formyl-5α-cholest-2-ene (2a; 0.46 g,
1 mmol), urea (0.18 g, 3.0 mmol) and samarium chloride hexahydrate (0.55 g, 1.5 mmol)
were mixed intimately in a mortar and irradiated in an open reaction vessel of a Synthwave
402 Prolabo focused microwave reactor (manufactured by M/s Prolabo, 54 rue Roger Salengro,
Cedex, France) after setting the reaction temperature at 140 °C and the power at 80%
(maximum output 300 Watts). On completion of reaction (vide TLC), the reaction mixture
was treated with H2O (50 mL) and extracted with CH2Cl2 (3 × 30 mL). The organic portion was washed with H2O, dried over anhyd Na2SO4 and the solvent was removed to obtain a crude product. Column chromatography separation
using EtOAc-hexane (1:9) as eluent over silica gel afforded 4a in 82% yield. This procedure was followed for the synthesis of all products listed
in Table
[1]
.
<A NAME="RD30106ST-16">16</A>
Spectral and analytical data of selected compounds:
Compound 4a: mp 90-92 °C; R
f
= 0.3 (EtOAc-hexane, 20:80). IR (KBr): 2925, 1641, 1582, 1559, 1442 cm-1. 1H NMR (300 MHz. CDCl3): δ = 8.28 (br s, 1 H), 2.65 (s, 3 H), 0. 96 (s, 3 H), 0.74 (s, 3 H), 0.91-2.78 (m,
38 H). 13C NMR (75 MHz, CDCl3): δ = 165.4, 165.4, 157.7, 126.3, 56.8, 54.1, 42.9 (3 × C), 39.9 (2 × C), 36.6, 36.4,
36.1 (2 × C), 35.4, 31.9, 30.0, 28.9, 28.5, 28.3, 25.8, 24.6, 24.2, 23.1, 22.9, 21.7,
19.1, 12.4, 11.9. MS (ESI): m/z = 437 [M+ + 1]. Anal. Calcd for C30H48N2: C, 82.51; H, 11.08; N, 6.41. Found: C, 82.28; H, 10.95; N, 6.59.
Compound 4b: gum; R
f
= 0.3 (EtOAc-hexane, 30:70). IR (KBr): 2925, 1631, 1578, 1552, 1440 cm-1. 1H NMR (300 MHz, CDCl3): δ = 8.24 (br s, 1 H), 6.19 (br s, 1 H), 2.64 (s, 3 H), 0.94 (s, 3 H), 0.88 (s,
3 H), 1.00-2.82 (m, 35 H). 13C NMR (75 MHz, CDCl3): δ = 166.6, 161.9, 160.0, 154.4, 126.3, 122.5, 56.6, 56.3, 54.2, 42.8, 40.1, 39.9
(2 × C), 39.5, 38.5, 36.5, 36.4, 36.2, 32.5, 31.6, 28.6, 28.4, 26.1, 24.7, 24.2, 23.2,
23.0, 19.1, 18.0, 12.3. MS (ESI): m/z = 435 [M+ + 1].
Compound 4d: mp 165-67 °C; R
f
= 0.3 (EtOAc-CHCl3, 10:90). IR (KBr): 2943, 1735, 1668, 1594, 1555, 1420, 1245, 1033, 755 cm-1. 1H NMR (300 MHz, CDCl3): δ = 8.31 (br s, 1 H), 5.35 (br s, 1 H), 4.52 (m, 1 H), 2.62 (s, 3 H), 1.97 (s,
3 H), 1.03 (s, 3 H), 0.92 (s, 3 H), 1.06-2.66 (m, 17 H). 13C NMR (75 MHz, CDCl3): δ = 181.9, 170.7, 166.5, 152.0, 140.7, 130.8, 122.1, 74.1, 56.2, 51.0, 46.3, 38.5,
37.3, 33.2, 31.7, 31.2, 29.1, 28.3, 28.1, 26.2, 21.6, 20.8, 19.7, 17.2. MS (ESI):
m/z = 381 [M+ + 1]. Anal. Calcd for C24H32N2O2: C, 75.75; H, 8.48; N, 7.36. Found: C, 75.90; H, 8.64; N, 7.17.
Compound 4e: oil; R
f
= 0.3 (EtOAc-CHCl3, 20:80). IR (KBr): 2925, 1641, 1583, 1553, 1438 cm-1. 1H NMR (300 MHz, CDCl3): δ = 8.29 (s 1 H), 2.83 (t, J = 5.96 Hz, 2 H), 2.70 (t, J = 6.05 Hz, 2 H), 2.65 (s, 3 H), 1.80-1.93 (m, 4 H). 13C NMR (75 MHz, CDCl3): δ = 166.1, 165.2, 157.2, 127.0, 32.1, 25.8, 25.5, 22.6, 22.5. MS (ESI): m/z = 149 [M+ + 1].
Compound 4h: mp 91-93 °C; R
f
= 0.5 (EtOAc-CHCl3, 10:90). IR (KBr): 2924, 1655, 1578, 1545, 1435, 825, 773 cm-1. 1H NMR (300 MHz, CDCl3): δ = 8.68 (d, J = 5.34 Hz, 1 H), 8.03 (d, J = 8.55 Hz, 2 H), 7.46-7.49 (m, 3 H), 2.80 (s, 3 H). 13C NMR (75 MHz, CDCl3): δ = 168.9, 163.2, 158.1, 137.5, 135.7, 129.6 (2 × C), 128.9 (2 × C), 114.1, 26.7.
MS (ESI): m/z = 205 [M+ + 1]. Anal. Calcd for C11H9N2Cl: C, 64.55; H, 4.43; N, 13.68. Found: C, 64.41; H, 4.33; N, 13.40.
<A NAME="RD30106ST-17">17</A>
Kagan HB.
Namy JL.
Tetrahedron
1986,
42:
6573
<A NAME="RD30106ST-18">18</A>
Cooper HBH, and
Spencer HW. inventors; US Patent 6077491.